117 related articles for article (PubMed ID: 1304826)
1. In vivo effects of thymic hormones (Imunotim) on immunologic parameters of patients with secondary immunodeficiency diseases.
Crişan M; Stugren C; Gal O; Herold A; Bucurenci N
Roum Arch Microbiol Immunol; 1992; 51(4):213-24. PubMed ID: 1304826
[TBL] [Abstract][Full Text] [Related]
2. Immunologic and clinical investigation on a bovine thymic extract. Therapeutic applications in primary immunoedificiencies.
Aiuti F; Ammirati P; Fiorilli M; D'Amelio R; Franchi F; Calvani M; Businco L
Pediatr Res; 1979 Jul; 13(7):797-802. PubMed ID: 314621
[TBL] [Abstract][Full Text] [Related]
3. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
Mel'nik VP
Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
[TBL] [Abstract][Full Text] [Related]
4. [T-lymphocyte subpopulations in autoimmune and subacute thyroiditis treated with T-activin].
Sakaeva NA; Balabolkin MI; Tabagari DZ
Sov Med; 1989; (10):39-41. PubMed ID: 2617340
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocyte changes after benign gastrointestinal surgery. Role of thymostimulin in reversing the postoperative immunodepression seen in humans.
Garcia-Valdecasas JC; Martinez A; Lopoez-Boado MA; de Lacy AM; Cugat E; Grande L; Fuster J; Visa J; Pera C
Hepatogastroenterology; 1988 Oct; 35(5):219-22. PubMed ID: 2976389
[TBL] [Abstract][Full Text] [Related]
6. [Chronic nonspecific lung diseases, immunological deficiency and the means of its correction].
Chuchalin AG; Arion VIa; Babushkina VA; Krotova SB; Portnova AP
Ter Arkh; 1984; 56(10):10-4. PubMed ID: 6335304
[TBL] [Abstract][Full Text] [Related]
7. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
[No Abstract] [Full Text] [Related]
8. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
[No Abstract] [Full Text] [Related]
9. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
[No Abstract] [Full Text] [Related]
10. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of thymostimulin and study of lymphocyte-dependent antibacterial activity in children with recurrent respiratory infections.
De Mattia D; Decandia P; Ferrante P; Pace D; Martire B; Ciccarelli M; Caradonna L; Ribaud MR; Jirillo E; Schettini F
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):447-59. PubMed ID: 8227971
[TBL] [Abstract][Full Text] [Related]
12. [Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].
Franchuk AE; Benzar ZT
Akush Ginekol (Mosk); 1990 Sep; (9):40-3. PubMed ID: 2278306
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience with thymostimulin (TP-1) therapy. Preliminary findings].
Altomonte L; Zoli A; Siena D; Alessi F; Pestillo L; Mirone L
Minerva Med; 1986 Jun; 77(26):1243-7. PubMed ID: 3725151
[TBL] [Abstract][Full Text] [Related]
14. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
[TBL] [Abstract][Full Text] [Related]
15. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
Sarkisian SV
Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
[TBL] [Abstract][Full Text] [Related]
16. [Principles of a differentiated immunocorrective therapy].
Perederiĭ VG; Zemskov AM
Vrach Delo; 1988 Aug; (8):71-4. PubMed ID: 3264643
[No Abstract] [Full Text] [Related]
17. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
[TBL] [Abstract][Full Text] [Related]
18. Thymosin activity in patients with cellular immunodeficiency.
Wara DW; Goldstein AL; Doyle NE; Ammann AJ
N Engl J Med; 1975 Jan; 292(2):70-4. PubMed ID: 1078552
[TBL] [Abstract][Full Text] [Related]
19. The thymus gland in secondary immunodeficiency.
Linder J
Arch Pathol Lab Med; 1987 Dec; 111(12):1118-22. PubMed ID: 3314787
[TBL] [Abstract][Full Text] [Related]
20. [Principles of immunocorrective therapy using the thymus preparation T-activin].
Arion VIa; Ivanushkin EF
Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
